并非所有绝经前乳腺癌患者都会经历他莫昔芬治疗对其骨密度的负面影响。 - Suppr

Suppr

超能文献

Not all patients with premenopausal breast cancer will experience the negative effects of tamoxifen treatment on their bone mineral density.

作者信息

Altundag Kadri

机构信息

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800, Ankara, Turkey.

出版信息

Breast Cancer. 2024 Sep;31(5):997. doi: 10.1007/s12282-024-01595-1. Epub 2024 May 18.

DOI:10.1007/s12282-024-01595-1

PMID:38762702

Abstract

摘要

相似文献

Not all patients with premenopausal breast cancer will experience the negative effects of tamoxifen treatment on their bone mineral density.并非所有绝经前乳腺癌患者都会经历他莫昔芬治疗对其骨密度的负面影响。

Breast Cancer. 2024 Sep;31(5):997. doi: 10.1007/s12282-024-01595-1. Epub 2024 May 18.

Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis.绝经前乳腺癌患者他莫昔芬治疗对骨密度的不良影响：系统评价和荟萃分析。

Breast Cancer. 2024 Jul;31(4):717-725. doi: 10.1007/s12282-024-01586-2. Epub 2024 Apr 27.

Endogenous estrogen levels, bone mineral density and estrogen receptor status in breast cancer.乳腺癌中的内源性雌激素水平、骨密度和雌激素受体状态

Breast Cancer Res Treat. 2005 Jan;89(2):213. doi: 10.1007/s10549-004-1537-z.

Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.辅助内分泌治疗随机试验中早期乳腺癌绝经前女性的骨矿物质密度

J Clin Oncol. 2004 Sep 15;22(18):3694-9. doi: 10.1200/JCO.2004.08.148.

Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.绝经前接触他莫昔芬导致子宫内膜异位症恶化。

Am J Obstet Gynecol. 2000 Aug;183(2):507-8. doi: 10.1067/mob.2000.105966.

Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.乳腺癌患者管理中的争议：绝经前女性的辅助内分泌治疗

J Clin Oncol. 2008 Feb 10;26(5):745-52. doi: 10.1200/JCO.2007.14.3016.

Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.辅助化疗后他莫昔芬治疗对绝经前患者骨密度的影响因月经状态而异，呈相反作用。

J Clin Oncol. 2006 Feb 1;24(4):675-80. doi: 10.1200/JCO.2005.02.3515.

Bone mineral density following surgical oophorectomy and tamoxifen adjuvant therapy for breast cancer.乳腺癌术后卵巢切除术和他莫昔芬辅助治疗后的骨密度。

Cancer. 2013 Nov 1;119(21):3746-52. doi: 10.1002/cncr.28302. Epub 2013 Aug 20.

Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.他莫昔芬对绝经后早期乳腺癌女性骨矿物质密度及代谢的影响。

Med Oncol. 2004;21(2):117-21. doi: 10.1385/MO:21:2:117.

Acute abdomen due to endometriosis in a premenopausal woman taking tamoxifen.

Eur J Obstet Gynecol Reprod Biol. 2003 Aug 15;109(2):234-5. doi: 10.1016/s0301-2115(03)00004-6.

引用本文的文献

Impact of Endocrine Therapy on Osteoporosis Risk in Women with Breast Cancer Across Different Hormonal Stages: A Review.内分泌治疗对不同激素阶段乳腺癌女性骨质疏松风险的影响：一项综述

Curr Oncol. 2025 May 26;32(6):305. doi: 10.3390/curroncol32060305.

本文引用的文献

Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer.获得性耐药和逆转过程中核糖体谱的改变与炎性乳腺癌化疗的病理反应相关。

NPJ Breast Cancer. 2024 Jul 29;10(1):65. doi: 10.1038/s41523-024-00664-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验